
James E. Udelson
Articles
-
2 months ago |
radcliffecardiology.com | James E. Udelson |Gregg W. Stone |Nisha Bansal |Antonio Ceriello
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the Reprieve DMS.
-
Nov 15, 2024 |
jamanetwork.com | James E. Udelson |Clyde Yancy |Gregg C. Fonarow
Interpreting Health Status Measures in Patients With Heart Failure—What Counts Interpreting Population Mean Treatment Effects in the Kansas City Cardiomyopathy Questionnaire Mohammad Abdel Jawad, MD; Philip G. Jones, MS; Suzanne V. Arnold, MD, MHA; David J. Cohen, MD, MSc; Charles F. Sherrod, MD; Mirza S. Khan, MD; Nobuhiro Ikemura, MD, PhD; Paul S. Chan, MD, MSc; John A.
-
Nov 6, 2024 |
jamanetwork.com | Gregg C. Fonarow |James E. Udelson |Clyde Yancy
Heart Failure With Preserved Ejection Fraction—A Role for Invasive Hemodynamics Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation Jwan A. Naser, MBBS; Tomonari Harada, MD, PhD; Yogesh N. Reddy, MBBS; Sorin V. Pislaru, MD, PhD; Hector I. Michelena, MD; Christopher G. Scott, MS; Austin M. Kennedy, BS; Patricia A. Pellikka, MD; Vuyisile T. Nkomo, MD, MPH; Mackram F. Eleid, MD; Barry A.
-
Oct 25, 2023 |
jamanetwork.com | James E. Udelson |Gregg C. Fonarow |Robert O. Bonow |Divaka Perera
Realigning Priorities in the Evaluation and Management of Patients With Heart Failure Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Divaka Perera, MA, MD; Matthew Ryan, PhD; Holly P. Morgan, MBBCh; John P. Greenwood, PhD; Mark C. Petrie, MD; Matthew Dodd, MSc; Roshan Weerackody, PhD; Peter D.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →